These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 7048616

  • 1. Regulatory aspects of teratology: role of the Food and Drug Administration.
    Kelsey FO.
    Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616
    [Abstract] [Full Text] [Related]

  • 2. Teratogen update: evaluation of the reproductive and developmental risks of caffeine.
    Christian MS, Brent RL.
    Teratology; 2001 Jul; 64(1):51-78. PubMed ID: 11410911
    [Abstract] [Full Text] [Related]

  • 3. Reproductive toxicology guidelines: comparison and application.
    Beltrame D, Mazué G.
    Ann Ist Super Sanita; 1993 Jul; 29(1):3-14. PubMed ID: 8129269
    [Abstract] [Full Text] [Related]

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials.
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [Abstract] [Full Text] [Related]

  • 5. Methods of evaluating the alleged teratogenicity of environmental agents.
    Brent RL.
    Prog Clin Biol Res; 1985 Mar; 163C():191-5. PubMed ID: 3991621
    [No Abstract] [Full Text] [Related]

  • 6. The history and contemporary challenges of the US Food and Drug Administration.
    Borchers AT, Hagie F, Keen CL, Gershwin ME.
    Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043
    [Abstract] [Full Text] [Related]

  • 7. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT, Barash PG.
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [Abstract] [Full Text] [Related]

  • 8. Knowledge transfer and translation: examining how teratogen information is disseminated.
    Shahin I, Einarson A.
    Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):956-61. PubMed ID: 21948595
    [Abstract] [Full Text] [Related]

  • 9. Regulatory issues concerning the safety, efficacy and quality of herbal remedies.
    Rousseaux CG, Schachter H.
    Birth Defects Res B Dev Reprod Toxicol; 2003 Dec; 68(6):505-10. PubMed ID: 14745988
    [Abstract] [Full Text] [Related]

  • 10. Lessons learned from independent central review.
    Ford R, Schwartz L, Dancey J, Dodd LE, Eisenhauer EA, Gwyther S, Rubinstein L, Sargent D, Shankar L, Therasse P, Verweij J.
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [Abstract] [Full Text] [Related]

  • 11. Drug labeling for teratogenicity: requirements of the U.S. Food and Drug Administration.
    Kelsey FO.
    Prog Clin Biol Res; 1985 Jan; 163C():155-9. PubMed ID: 3991617
    [No Abstract] [Full Text] [Related]

  • 12. Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors.
    Brent RL.
    Pediatrics; 2004 Apr; 113(4 Suppl):957-68. PubMed ID: 15060188
    [Abstract] [Full Text] [Related]

  • 13. Food and Drug Administration proposed testing guidelines for reproduction studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
    Collins TF, Sprando RL, Shackelford ME, Hansen DK, Welsh JJ.
    Regul Toxicol Pharmacol; 1999 Aug; 30(1):29-38. PubMed ID: 10464044
    [Abstract] [Full Text] [Related]

  • 14. Reproductive and teratological risks of caffeine.
    Nash J, Persaud TV.
    Anat Anz; 1988 Aug; 167(4):265-70. PubMed ID: 3066235
    [Abstract] [Full Text] [Related]

  • 15. Cyberpharmacies and the role of the US Food And Drug Administration.
    Henney JE.
    J Med Internet Res; 2001 Aug; 3(1):E3. PubMed ID: 11720945
    [Abstract] [Full Text] [Related]

  • 16. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
    Public Affairs Committee of the Teratology Society.
    Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
    [No Abstract] [Full Text] [Related]

  • 17. The complexities of solving the problem of human malformations.
    Brent RL.
    Clin Perinatol; 1986 Sep; 13(3):491-503. PubMed ID: 3533363
    [Abstract] [Full Text] [Related]

  • 18. Records and reports regulations for radiation emitting electronic products--FDA. Final rule.
    Fed Regist; 1995 Sep 19; 60(181):48374-87. PubMed ID: 10151183
    [Abstract] [Full Text] [Related]

  • 19. Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
    Collins TF, Sprando RL, Shackelford ME, Hansen DK, Welsh JJ.
    Regul Toxicol Pharmacol; 1999 Aug 19; 30(1):39-44. PubMed ID: 10464045
    [Abstract] [Full Text] [Related]

  • 20. Potential subversion of pregnancy prevention program in the managed care setting.
    Wilkin JK.
    Arch Dermatol; 1997 Feb 19; 133(2):243-4. PubMed ID: 9041846
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.